US Stock MarketDetailed Quotes
ORMP Oramed Pharmaceuticals
- 2.460
- +0.160+6.96%
Close Apr 26 16:00 ET
- 2.480
- +0.020+0.81%
Post 17:38 ET
99.68MMarket Cap17.57P/E (TTM)
2.480High2.310Low84.60KVolume2.320Open2.300Pre Close203.38KTurnover0.23%Turnover Ratio17.57P/E (Static)40.52MShares5.25052wk High0.61P/B89.77MFloat Cap1.67052wk Low--Dividend TTM36.49MShs Float31.730Historical High--Div YieldTTM7.39%Amplitude0.091Historical Low2.404Avg Price1Lot Size
About Oramed Pharmaceuticals Company
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Company Profile
SymbolORMP
Company NameOramed Pharmaceuticals
Listing DateMar 9, 2004
Founded2002
CEOMr. Nadav Kidron
MarketNASDAQ
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1185 Avenue of the Americas,3rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-844-967-2633
Websitehttp://www.oramed.com
Company Executives
- Name
- Position
- Salary
- Nadav Kidron
- President, Chief Executive Officer and Chairman of the Board
- 6.83M
- David Silberman
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.27M
- Dr. Miriam Kidron,PhD
- Director and Chief Scientific Officer
- 3.07M
- Joshua Hexter
- Chief Operating and Business Officer
- 608.83K
- Benjamin Shapiro
- Director
- --
- Dr. Daniel Aghion
- Director
- --
- Yehuda Reznick
- Director
- --
- Dr. Arie Mayer, PhD
- Independent Director
- 401.26K
- Leonard Sank
- Independent Director
- 305.97K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg